Medicago is a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic proteins for the treatment of infectious diseases worldwide. The company provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles (VLPs) and manufacturing technologies using a transient expression system, which produces recombinant vaccine antigens in plants. For more information, visit the company’s Web site: http://www.medicago.com

Let us hear your thoughts below: